Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Aug 28, 2026

OACC — Oaktree Acquisition Corp. III Life Sciences Dilution Risk Tracker

Track OACC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OACC — Get alerts when the score changes →

As of August 28, 2026, Oaktree Acquisition Corp. III Life Sciences (OACC) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Oaktree Acquisition Corp. III Life Sciences has a market capitalization of $262.54M, 19.78M shares outstanding, 51 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for OACC.
🔔 Track OACC — Get forecast alerts →

Market Data

Market Cap$262.54M
Shares Outstanding19.78M
Float18.37M
Cash$1.18M
Debt$11.8K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 9.6% shares (2026Q1 vs prior)
51 institutional holders · 17.43M shares
#1 AQR Arbitrage LLC 1.32M shares
#2 GOLDMAN SACHS GROUP INC 1.06M shares
#3 Decagon Asset Management LLP 1.00M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.9K
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual OACC Dilution Snapshot

Oaktree Acquisition Corp. III Life Sciences (OACC) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track OACC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OACC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ SPAC / Warrants sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OACC
OACC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.